Amidst a backdrop of strengthening European indices, with Germany's DAX showing notable gains, investors are keenly observing market shifts and potential opportunities. In such a climate, identifying stocks that appear undervalued relative to their estimated fair values could offer attractive prospects for discerning investors. Top 10 Undervalued Stocks Based On Cash Flows In Germany Name Current Price Fair Value (Est) Discount (Est) Stabilus (XTRA:STM) €43.75 €80.12 45.4% Novem Group (XTRA:NVM) €5.24 €10.24 48.8% PSI Software (XTRA:PSAN) €22.60 €43.47 48% Stratec (XTRA:SBS) €44.25 €81.91 46% Wolftank-Adisa Holding (XTRA:WAH) €11.30 €22.45 49.7% SBF (DB:CY1K) €2.92 €5.77 49.4% CHAPTERS Group (XTRA:CHG) €24.80 €46.79 47% Rubean (DB:R1B) €5.90 €10.99 46.3% MTU Aero Engines (XTRA:MTX) €246.70 €419.73 41.2% Your Family Entertainment (DB:RTV) €2.44 €4.52 46% Click here to see the full list of 30 stocks from our Undervalued German Stocks Based On Cash Flows screener. Let's take a closer look at a couple of our picks from the screened companies. adesso Overview: Adesso SE operates as an IT service provider in Germany, Austria, Switzerland, and internationally, with a market capitalization of approximately €0.57 billion. Operations: The company generates revenue primarily through two segments: IT Services (€1.31 billion) and IT Solutions (€119.88 million). Estimated Discount To Fair Value: 15.2% Adesso SE, priced at €87, is considered undervalued based on discounted cash flow analysis, with an estimated fair value of €102.61. Despite trading 15.2% below this valuation and showing potential with a forecasted annual revenue growth of 11.9%, its financial robustness is questionable as earnings barely cover interest payments. Profitability is expected within three years, yet the projected return on equity remains modest at 13.6%. Recent engagements include presentations at Big Data & AI World Frankfurt, highlighting its active role in data-driven sectors. The analysis detailed in our adesso growth report hints at robust future financial performance. Click to explore a detailed breakdown of our findings in adesso's balance sheet health report. XTRA:ADN1 Discounted Cash Flow as at Jul 2024 adidas Overview: Adidas AG operates globally, designing, developing, producing, and marketing athletic and sports lifestyle products across various regions, with a market capitalization of approximately €39.51 billion. Operations: The company generates revenue from several geographic segments, with €5.16 billion from North America, €3.20 billion from Greater China, and €2.31 billion from Latin America. Estimated Discount To Fair Value: 34.8% Adidas AG, currently trading at €221.3, is significantly undervalued with a DCF-based fair value of €339.51, reflecting a 34.8% discount. After turning profitable this year with first-quarter sales rising to €5.46 billion from €5.27 billion and net income hitting €170 million against last year's loss, the outlook is bullish. Earnings are expected to surge by 41.3% annually over the next three years, outpacing the German market forecast of 18.7%. Recent presentations in Stockholm and upcoming events in Paris and Warsaw underscore its active market engagement. Insights from our recent growth report point to a promising forecast for adidas' business outlook. Navigate through the intricacies of adidas with our comprehensive financial health report here. XTRA:ADS Discounted Cash Flow as at Jul 2024 Gerresheimer Overview: Gerresheimer AG operates globally, specializing in the production and sale of medical packaging and drug delivery devices, with a market capitalization of approximately €3.56 billion. Operations: The company generates revenue through three main segments: Plastics & Devices (€1.09 billion), Advanced Technologies (€6.43 million), and Primary Packaging Glass (€908.16 million). Estimated Discount To Fair Value: 21.7% Gerresheimer AG, priced at €103, is considered undervalued with a DCF valuation of €131.55, suggesting a 21.7% potential upside. While its revenue growth is slower compared to some market segments at 10.3% annually, earnings are expected to increase significantly by 20.41% per year over the next three years, outpacing the broader German market's forecast of 18.7%. However, it carries a high level of debt and its Return on Equity is projected to be low at 13.8%. Recent activities include an earnings guidance update projecting up to 15% revenue growth by 2025 and consistent profit growth in Q1 reports for 2024. The growth report we've compiled suggests that Gerresheimer's future prospects could be on the up. Dive into the specifics of Gerresheimer here with our thorough financial health report. XTRA:GXI Discounted Cash Flow as at Jul 2024 Summing It All Up Click this link to deep-dive into the 30 companies within our Undervalued German Stocks Based On Cash Flows screener. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Want To Explore Some Alternatives? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include XTRA:ADN1XTRA:ADS and XTRA:GXI. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
Unveiling Three German Exchange Stocks Believed To Be Trading Below Estimated Fair Values
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...